Home › Cancer (all types) › NCT02478931

Study of Personalized Cancer Therapy to Determine Response and Toxicity

UCSD Profile Related Evidence Determining Individualized Cancer Therapy (UCSD PREDICT)

Who can join

Ages 7 and older · All sexes

Inclusion Criteria:

* Must be willing to provide informed consent, parent permission, or assent

Exclusion Criteria:

* Subjects unable to give informed consent, parent permission, or assent

About the study

The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor. Optional research tests may be performed on tissue, body cavity fluid, blood or urine provided, discarded biological samples taken during routine care that would normally be disposed of and not saved, or on blood samples collected for this study. These research tests will be used to create a "profile" of the collected specimens which will describe unique characteristics about the genes involved in a person's cancer. The tests will also help researchers look for biomarkers that may help predict how people respond to treatment.

Sponsor: Shu Mei Kato · Participants: 10,000 · Started: Sep 5, 2013

Contact the study team

• Lee Suzanna, MPH · Phone: (858) 534-1306
• Michaela Doering, BS · Phone: (858) 657-7512

Official record on ClinicalTrials.gov — NCT02478931

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.